Retisert (fluocinolone acetonide intravitreal implant) / EyePoint Pharma, Bausch Health  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Retisert (fluocinolone acetonide intravitreal implant) / Bausch Health, EyePoint Pharma
NCT00636493: Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)

Completed
1
30
US
fluocinolone acetonide (Retisert Implant), Retisert Implant, Bausch and Lomb, Rochester, NY
Glenn Jaffe, Bausch & Lomb Incorporated
Retinal Vein Occlusion
05/09
05/09
NCT00570479: Prophylactic Anecortave Acetate in Patients With a Retisert Implant

Completed
1
12
US
anecortave acetate
Texas Retina Associates, Alcon Research
Uveitis, Posterior, Glaucoma
03/10
03/10

Download Options